In support of this, patients carrying the L232P mutation in CYP51A1 presented with congenital cataracts, neonatal cholestatic jaundice, elevated liver enzymes, and hyperferritinemia, indicating that CYP51A1 mutations may underlie a syndromic disorder affecting both ocular and hepatic systems. This evidence concerns the gene CYP51A1 and Developmental cataract.